Literature DB >> 4856154

An exponential model relating censored survival data and concomitant information for prostatic cancer patients.

D P Byar, R Huse, J C Bailar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4856154     DOI： 10.1093/jnci/52.2.321

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy.

Authors:  H Fuse; I Mizuno; T Yokoyama; M Sakamoto; T Katayama
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 2.  An analysis of predictor variables for adjuvant treatment of breast cancer.

Authors:  S Kister; J Aroesty; W Rogers; C Huber; K Willis; P Morrison; G Shangold; T Lincoln
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Tumour markers in urology: aids in cancer diagnosis and management.

Authors:  B Wahren
Journal:  Urol Res       Date:  1979-06-22

4.  The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer: Gunma Urological Oncology Study Group investigation.

Authors:  K Imai; T Suzuki; M Kobayashi; H Yamanaka; Y Tomaru; J Sato
Journal:  Jpn J Cancer Res       Date:  1990-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.